ArticleEMBO molecular medicine2018

Brain-targeted stem cell gene therapy corrects mucopolysaccharidosis type II via multiple mechanisms.

Hélène Fe Gleitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.